Vor Biopharma (VOR)

• Market cap: $296M
• 1 day: 5.79%
• 5 days: 13.42%
• 1 month: 26.12%
• 3 months: -57.38%
• 6 months: -73.39%
• Year to date: 16.15%
• 1 year: -56.67%
• 5 years: -98.2%
• 10 years: -98.2%
• Sector: Healthcare
• Industry: Biotechnology

About: Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.

Employees: 168